content top

Fluid Dynamics Among Different 25-gauge Systems: Principles for Use in Vitreoretinal Surgery

http://www.evrs.eu/medias/2006/congress/Fluid-Dynamics-Among-Different-25-gauge-Systems:-Principles-for-Use-in-Vitreoretinal-Surgery.swf http://www.evrs.eu/medias/2006/congress/Fluid-Dynamics-Among-Different-25-gauge-Systems:-Principles- for Use-in-Vitreoretinal-Surgery.flv Michel Eid Farah, MD, PhD (São Paulo, Brazil), Octaviano Magalhães Jr., MD (São Paulo, Brazil), Mauricio Maia, MD (São Paulo, Brazil), André Maia, MD (São Paulo,...

Read More

Intravitreal Bevacizumab (Avastin) for Proliferative Diabetic Retinopathy

J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Lihteh Wu, MD (San Jose, Costa Rica), Juan G. Sanchez, MD (Caracas, Venezuela), Mauricio Maia, MD (Sao Paulo, Brazil), Mario J. Saravia, MD (Buenos Aires, Argentina) PURPOSE: To study the effects of intravitreal bevacizumab (Avastin) on retinal neovascularization (RN) in patients with proliferative diabetic retinopathy (PDR). METHODS: Retrospective study of patients with RN due to PDR who...

Read More

Primary Intravitreal Bevacizumab (Avastin) for the Treatment of CNV Secondary to AMD: Results of the Pan-American Collaborative Retina Study Group

http://www.evrs.eu/medias/2006/congress/Primary-Intravitreal-Bevacizumab-(Avastin)-for-the-Treatment-of-CNV-Secondary-to-AMD:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.swf Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Hugo Quiroz-Mercado, MD (Mexico City, Mexico), Juan G. Sanchez, MD (Caracas, Venezuela), Lihteh Wu, MD (San Jose, Costa Rica), Jose Dalma-Weiszhausz,...

Read More

Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Diabetic Macular Edema: Results of the Pan-American Collaborative Retina Study Group

http://www.evrs.eu/medias/2006/congress/Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Diabetic-Macular-Edema:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.swf http://www.evrs.eu/medias/2006/congress/Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Diabetic-Macular-Edema:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.flv J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Jans...

Read More

Safety of an Intravitreal Injection of Bevacizumab (Avastin®): Results of a Multicenter Trial

Lihteh Wu, MD (San Jose, Costa Rica), Maria A. Martinez- Castellanos, MD (Mexico City, Mexico), Hugo Quiroz-Mercado, MD (Mexico City, Mexico), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Michel Eid Farah, MD, PhD (São Paulo, Brazil), Maria H. Berrocal, MD (Santurce, PR), Jose A. Roca, MD (Lima, Peru), Francisco J. Rodriguez, MD (Bogota, Colombia), Mauricio Maia, MD (São Paulo, Brazil), Teodoro Evans, MD (San Jose, Costa Rica), Pan...

Read More

Short Term Visual and Anatomic Outcomes Following Intravitreal Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

Jose A. Roca, MD (Lima, Peru), Lihteh Wu, MD (San Jose, Costa Rica), Fernando Arevalo, MD (Caracas, Venezuela), Mauricio Maia, MD (São Paulo, Brazil), Maria H. Berrocal, MD (Santurce, PR), Francisco J. Rodriguez, MD (Bogota, Colombia), Michel Eid Farah, MD, PhD (São Paulo, Brazil), Fabio Bom Aggio, MD (São Paulo, Brazil) PURPOSE: To describe the visual and anatomic outcomes of an intravitreal injection of 1.25 mg or 2.5 mg of bevacizumab...

Read More
content top